Cite
Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix
MLA
Gerszten, Kristina, et al. “Feasibility of Concurrent Cisplatin and Extended Field Radiation Therapy (EFRT) Using Intensity-Modulated Radiotherapy (IMRT) for Carcinoma of the Cervix.” Gynecologic Oncology, vol. 102, no. 2, Aug. 2006, pp. 182–88. EBSCOhost, https://doi.org/10.1016/j.ygyno.2005.12.044.
APA
Gerszten, K., Colonello, K., Heron, D. E., Lalonde, R. J., Fitian, I. D., Comerci, J. T., Selvaraj, R. N., & Varlotto, J. M. (2006). Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecologic Oncology, 102(2), 182–188. https://doi.org/10.1016/j.ygyno.2005.12.044
Chicago
Gerszten, Kristina, Kelly Colonello, Dwight E. Heron, Ron J. Lalonde, Issa D. Fitian, John T. Comerci, Raj N. Selvaraj, and John M. Varlotto. 2006. “Feasibility of Concurrent Cisplatin and Extended Field Radiation Therapy (EFRT) Using Intensity-Modulated Radiotherapy (IMRT) for Carcinoma of the Cervix.” Gynecologic Oncology 102 (2): 182–88. doi:10.1016/j.ygyno.2005.12.044.